Pediatric Conjunctivitis Management Guidelines

Mild Bacterial Conjunctivitis

A 5‑7 day course of any broad‑spectrum topical antibiotic (e.g., moxifloxacin or azithromycin) shortens symptom duration, reduces transmissibility, and enables earlier return to school, although the infection is often self‑limited. 1
Topical antibiotics achieve earlier clinical and microbiological remission than placebo, with the greatest benefit observed between days 2‑5 of therapy. 1
In resource‑limited settings, povidone‑iodine 1.25 % ophthalmic solution is comparable in effectiveness to topical antibiotics. 2

Defined by copious purulent discharge, ocular pain, and marked inflammation. 1
Obtain conjunctival cultures and Gram‑stain slides, especially when gonococcal infection is suspected. 1
Empiric coverage for methicillin‑resistant Staphylococcus aureus (MRSA) should be considered in severe cases due to rising prevalence. 3
Neonates in intensive care with low birth weight/gestational age frequently develop gram‑negative conjunctivitis resistant to gentamicin and may require compounded vancomycin. 3

Systemic antibiotic therapy is mandatory for eradication of Neisseria gonorrhoeae. 1
Saline lavage can be added for patient comfort and to accelerate resolution. 3
If corneal involvement is present, adjunctive topical therapy for bacterial keratitis should be instituted. 3
Consider the possibility of sexual abuse in affected children. 2
Daily ophthalmic follow‑up with visual‑acuity testing and slit‑lamp examination is required until complete resolution. 3
Prior to confirming N. gonorrhoeae, rule out Neisseria meningitidis. 3

Systemic antimicrobial therapy is required because more than half of affected infants have concurrent infection at other sites (e.g., nasopharynx, genital tract, lungs). 2
No evidence supports the addition of topical antibiotics to systemic treatment. 2
Treatment failure occurs in up to 19 % of cases; therefore, re‑evaluation after therapy is essential. 2
Consider sexual abuse in children diagnosed with chlamydial conjunctivitis. 2
In settings with limited resources, povidone‑iodine 1.25 % ophthalmic solution is an acceptable alternative. 3

The condition is self‑limited, typically resolving within 2‑3 weeks. 4
Topical corticosteroids may be used for symptomatic sub‑epithelial infiltrates causing blurred vision or photophobia, employing low‑penetration agents (e.g., fluorometholone or loteprednol) and tapering to the minimum effective dose. 4

First‑line topical therapy: ganciclovir 0.15 % gel 3‑5 times daily (preferred over trifluridine due to lower ocular surface toxicity). 4
Oral antivirals (acyclovir, valacyclovir, or famciclovir) are appropriate adjuncts. 4
Topical corticosteroids should be avoided because they exacerbate HSV epithelial infection. 4
Neonates with ocular HSV require urgent pediatric consultation due to risk of life‑threatening systemic disease. 4
Follow‑up within 1 week with visual‑acuity and slit‑lamp examination is recommended. 4

Apply topical antibiotics to prevent secondary bacterial infection of necrotic vesicles. 4
For persistent disease, prescribe oral acyclovir 800 mg five times daily (or equivalent valacyclovir/famciclovir regimen) for 7 days. 4
Topical antivirals alone are not effective but may be used as adjunctive therapy. 4

Indicated treatment for symptomatic lesions includes incision and curettage, simple excision, excision with cautery, or cryotherapy. 1
Early identification and treatment of nascent lesions reduce recurrence risk. 1
Conjunctivitis may persist for weeks after lesion removal. 1

Visual loss, moderate or severe ocular pain, severe purulent discharge, corneal involvement, conjunctival scarring, lack of response to therapy, recurrent episodes, history of HSV eye disease, or immunocompromised state. 3

Bacterial conjunctivitis without improvement: reassess in 3‑4 days. 2
Viral conjunctivitis: return for evaluation if symptoms persist beyond 2‑3 weeks. 4
Gonococcal conjunctivitis: schedule daily visits until complete resolution. 3

In pediatric patients, viral conjunctivitis most often presents bilaterally with a follicular reaction【5】.

Red‑flag signs indicating possible gonococcal infection include marked eyelid edema, copious purulent discharge, pre‑auricular lymphadenopathy, and any corneal involvement【6】【5】.
If untreated, gonococcal conjunctivitis can lead to serious sequelae such as corneal perforation, septicemia, arthritis, and meningitis【6】【5】.
The presence of gonococcal conjunctivitis in a child should prompt evaluation for possible sexual abuse【6】.

Typical findings in infants with chlamydial conjunctivitis are eyelid edema, bulbar conjunctival injection, and a discharge that may be purulent, mucopurulent, or blood‑stained, without follicles【6】【5】.

Immediate ophthalmology referral is required when corneal involvement (e.g., infiltrate, ulcer, or opacity) is identified【6】.
Both gonococcal and chlamydial conjunctivitis require systemic antimicrobial therapy; reliance on topical antibiotics alone is insufficient and may result in serious complications【6】【5】.

All statements are based on peer‑reviewed evidence from the cited ophthalmology literature; specific levels of evidence were not provided.